-
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
(PAR-23-286)
National Cancer Institute
Application Receipt Date(s): October 14, 2026
-
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)
(PAR-23-287)
National Cancer Institute
Application Receipt Date(s): October 14, 2026
-
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)
(PAR-23-288)
National Cancer Institute
Application Receipt Date(s): October 14, 2026
-
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
(PAR-24-035)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date(s): Multiple dates, see announcement.
-
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
(PAR-24-036)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date(s): Multiple dates, see announcement.
-
Multi-sectoral preventive interventions that address social determinants of health in populations that experience health disparities (UG3/UH3, Clinical Trial Required)
(PAR-24-053)
Office of Disease Prevention
National Institute on Alcohol Abuse and Alcoholism
National Cancer Institute
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Heart, Lung, and Blood Institute
National Institute of Nursing Research
National Center for Complementary and Integrative Health
Office of Research on Women's Health
Office of Dietary Supplements
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): August 05, 2024
-
Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Optional)
(PAR-24-054)
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences
Application Receipt Date(s): September 14, 2026
-
Phased Research to Support Substance Use Epidemiology, Prevention, and Services Studies (R61/R33 Clinical Trials Optional)
(PAR-24-062)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): Multiple dates, see announcement.
-
Rural Community-Centered Drug Misuse Prevention and Harm Reduction Research: Addressing Implementation, Dissemination, and Equity Challenges across the Continuum of Care (R61/R33 Clinical Trial Only)
(RFA-DA-24-036)
National Institute on Drug Abuse
Office of Disease Prevention
Application Receipt Date(s): January 26, 2024
-
The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Required)
(RFA-DA-25-027)
National Institute on Drug Abuse
Application Receipt Date(s): March 13, 2024
-
National Drug Early Warning System Coordinating Center (U01 Clinical Trial Not Allowed)
(RFA-DA-25-029)
National Institute on Drug Abuse
Application Receipt Date(s): March 20, 2024
-
In Vivo High-Resolution Imaging for Inner Ear Visualization (R01 Clinical Trial optional)
(RFA-DC-24-004)
National Institute on Deafness and Other Communication Disorders
Application Receipt Date(s): February 3, 2025
-
Cooperative Agreement for In Vivo High-Resolution Imaging for Inner Ear Visualization (U01 Clinical Trial Required)
(RFA-DC-24-005)
National Institute on Deafness and Other Communication Disorders
Application Receipt Date(s): February 3, 2025
-
Advancing Genomic Medicine Research (R01 Clinical Trial Optional)
(RFA-HG-23-032)
National Human Genome Research Institute
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
-
Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
(RFA-HG-23-033)
National Human Genome Research Institute
National Cancer Institute
Application Receipt Date(s): February 11, 2025
-
Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)
(RFA-HG-23-048)
National Human Genome Research Institute
Application Receipt Date(s): Multiple dates, see announcement.
-
Coordinating Center to Support Multi-Sectoral Preventive Interventions that Address Social Determinants of Health in Populations that Experience Health Disparities (U24, Clinical Trial Not Allowed)
(RFA-OD-24-006)
Office of Disease Prevention
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): August 5, 2024